{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:00:57Z","timestamp":1792098057309,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,7,27]],"date-time":"2013-07-27T00:00:00Z","timestamp":1374883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00417-013-2436-y","type":"journal-article","created":{"date-parts":[[2013,7,26]],"date-time":"2013-07-26T12:42:33Z","timestamp":1374842553000},"page":"2627-2632","source":"Crossref","is-referenced-by-count":103,"title":["Tocilizumab treatment for refractory uveitis-related cystoid macular edema"],"prefix":"10.1007","volume":"251","author":[{"given":"Alfredo","family":"Ad\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Mesquida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Lloren\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Molins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pelegr\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,27]]},"reference":[{"key":"2436_CR1","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ophtha.2006.03.027","volume":"113","author":"CW Lardenoye","year":"2006","unstructured":"Lardenoye CW, van Kooij B, Rothova A (2006) Impact of macular edema on visual acuity in uveitis. Opthalmology 113:1146\u20131149","journal-title":"Opthalmology"},{"key":"2436_CR2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1076\/ocii.10.4.239.15589","volume":"10","author":"A Rothova","year":"2002","unstructured":"Rothova A (2002) Medical treatment of cystoid macular edema. Ocul Immunol Inflamm 10:239\u2013246","journal-title":"Ocul Immunol Inflamm"},{"key":"2436_CR3","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.ophtha.2012.02.018","volume":"119","author":"M D\u00edaz Llopis","year":"2012","unstructured":"D\u00edaz Llopis M, Salom D, Garcia de Vicu\u00f1a C, Cordero Coma M, Ortega G, Ortego N, Suarez de Figueroa M, Rio Pardo MJ, Fernandez-Cid C, Fonollosa A, Blanco R, Garcia-Aparicio AM, Benitez del Castillo JM, Olea JL, Arevalo JF (2012) Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients. Ophthalmology 119:1575\u20131581","journal-title":"Ophthalmology"},{"key":"2436_CR4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ajo.2004.04.066","volume":"138","author":"NN Markomichelakis","year":"2004","unstructured":"Markomichelakis NN, Theodossiadis PG, Pantelia E, Papaefthimiou S, Theodossiadis GP, Sfikakis PP (2004) Infliximab for chronic cystoid macular edema associated with uveitis. Am J Ophthalmol 138:648\u2013650","journal-title":"Am J Ophthalmol"},{"key":"2436_CR5","doi-asserted-by":"crossref","unstructured":"Ad\u00e1n A, Pelegr\u00edn L, Rey A, Lloren\u00e7 V, Mesquida M, Molins B, R\u00edos J, Keller J (2013) Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients. Retina. 2013 Mar 19. PMID:23514796","DOI":"10.1097\/IAE.0b013e31827e247b"},{"key":"2436_CR6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/09273948.2012.658467","volume":"20","author":"SR Taylor","year":"2012","unstructured":"Taylor SR, Lightman SL, Sugar EA, Jaffe GJ, Freeman WR, Altaweel MM, Kozak I, Holbrook JT, Jabs DA, Kempen JH (2012) The impact of macular edema on visual function in intermediate, posterior, and panuveitis. Ocul Immunol Inflamm 20:171\u2013181","journal-title":"Ocul Immunol Inflamm"},{"key":"2436_CR7","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/ard.2008.092932","volume":"67","author":"P Emery","year":"2008","unstructured":"Emery P, Keystone E, Tony HP, Cantagrel A, van Vollenhoven R, Sanchez A, Alecock E, Lee J, Kremer J (2008) IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis 67:1516\u20131523","journal-title":"Ann Rheum Dis"},{"key":"2436_CR8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509\u2013516","journal-title":"Am J Ophthalmol"},{"key":"2436_CR9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","volume":"92","author":"RB Nussenblatt","year":"1985","unstructured":"Nussenblatt RB, Palestine AG, Chan CC, Roberge F (1985) Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92:467\u2013471","journal-title":"Ophthalmology"},{"key":"2436_CR10","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.7150\/ijbs.4666","volume":"8","author":"T Tanaka","year":"2012","unstructured":"Tanaka T, Kishimoto T (2012) Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases. Int J Biol Sci 8:1227\u20131236","journal-title":"Int J Biol Sci"},{"key":"2436_CR11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/02713680701523147","volume":"32","author":"M Kramer","year":"2007","unstructured":"Kramer M, Monselise Y, Bahar I, Cohen Y, Weinberger D, Goldenberg-Cohen N (2007) Serum cytokine levels in active uveitis and remission. Curr Eye Res 32:669\u2013675","journal-title":"Curr Eye Res"},{"key":"2436_CR12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajo.2006.02.052","volume":"142","author":"B Kooij van","year":"2006","unstructured":"van Kooij B, Rothova A, Rijkers GT, de Groot-Mijnes JD (2006) Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema. Am J Ophthalmol 142:192\u2013194","journal-title":"Am J Ophthalmol"},{"key":"2436_CR13","first-page":"2003","volume":"17","author":"NV Valentincic","year":"2001","unstructured":"Valentincic NV, de Groot-Mijnes JD, Kraut A, Korosec P, Hawlina M, Rothova A (2001) Intraocular and serum cytokine profiles in patients with intermediate uveitis. Mol Vis 17:2003\u20132010","journal-title":"Mol Vis"},{"key":"2436_CR14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajo.2011.01.031","volume":"152","author":"JJ Kuiper","year":"2011","unstructured":"Kuiper JJ, Mutis T, de Jager W, de Groot-Mijnes JD, Rothova A (2011) Intraocular interleukin-17 and proinflammatory cytokines in HLA-A29-associated birdshot chorioretinopathy. Am J Ophthalmol 152:177\u2013182","journal-title":"Am J Ophthalmol"},{"key":"2436_CR15","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1167\/iovs.05-0444","volume":"46","author":"SJ Curnow","year":"2005","unstructured":"Curnow SJ, Falciani F, Durrani OM, Cheung CM, Ross EJ, Wloka K, Rauz S, Wallace GR, Salmon M, Murray PI (2005) Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci 46:4251\u20134259","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2436_CR16","first-page":"2659","volume":"39","author":"JV Ongkosuwito","year":"1998","unstructured":"Ongkosuwito JV, Feron EJ, van Doornik CE, Van der Lelij A, Hoyng CB, La Heij EC, Kijlstra A (1998) Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci 39:2659\u20132665","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2436_CR17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/rheumatology\/ken489","volume":"48","author":"T Yoshimura","year":"2009","unstructured":"Yoshimura T, Sonoda KH, Ohguro N, Ohsugi Y, Ishibashi T, Cua DJ, Kobayashi T, Yoshida A, Yoshimura A (2009) Involvement of Th17 cells and the effect of anti-IL-6. Therapy in autoimmune uveitis. Rheumatology 48:347\u2013354","journal-title":"Rheumatology"},{"key":"2436_CR18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.exer.2010.04.009","volume":"91","author":"S Hohki","year":"2010","unstructured":"Hohki S, Ohguro N, Haruta H, Nakai K, Terabe F, Serada S, Fujimoto M, Nomura S, Kawahata H, Kishimoto T, Naka T (2010) Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses. Exp Eye Res 91:162\u2013170","journal-title":"Exp Eye Res"},{"key":"2436_CR19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3109\/09273948.2011.606593","volume":"19","author":"A Muselier","year":"2011","unstructured":"Muselier A, Bielefeld P, Bidot S, Vinit J, Besancenot JF, Bron A (2011) Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis. Ocul Immunol Inflamm 19:382\u2013383","journal-title":"Ocul Immunol Inflamm"},{"key":"2436_CR20","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3899\/jrheum.120010","volume":"39","author":"C Tappeiner","year":"2012","unstructured":"Tappeiner C, Heinz C, Ganser G, Heiligenhaus A (2012) Is tocilizumab and effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis? J Rheumatolol 39:1294\u20131295","journal-title":"J Rheumatolol"},{"key":"2436_CR21","doi-asserted-by":"crossref","unstructured":"Oshitari T, Kajita F, Tobe A, Itami M, Yotsukura J, Baba T, Yamamoto S (2012) Refractory uveitis in patient with castleman disease successfully treated with tocilizumab. Case Rep Ophthalmol Med. Epub 2012 Nov 6. PMID:23198204","DOI":"10.1155\/2012\/968180"},{"issue":"3 Suppl 72","key":"2436_CR22","first-page":"S73","volume":"30","author":"P Urbaniak","year":"2012","unstructured":"Urbaniak P, Hasler P, Kretzschmar S (2012) Refractory neuro-Beh\u00e7et treated by tocilizumab: a case report. Clin Exp Rheumatol 30(3 Suppl 72):S73\u2013S75","journal-title":"Clin Exp Rheumatol"},{"key":"2436_CR23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s10165-011-0497-5","volume":"22","author":"T Hirano","year":"2012","unstructured":"Hirano T, Ohguro N, Hohki S, Hagihara K, Shima Y, Narazaki M, Ogata A, Yoshizaki K, Kumanogoh A, Kishimoto T, Tanaka T (2012) A case of Beh\u00e7et\u2019s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab. Mod Rheumatol 22:298\u2013302","journal-title":"Mod Rheumatol"},{"key":"2436_CR24","unstructured":"Ad\u00e1n A, Lloren\u00e7 V, Mesquida M, Pelegr\u00edn L (2012) Tocilizumab treatment for recalcitrant uveitic macular edema. Graefes Arch Clin Exp Ophthalmol. Dec 28 PMID:23271335"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2436-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-013-2436-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2436-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T17:32:51Z","timestamp":1563557571000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-013-2436-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,27]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["2436"],"URL":"https:\/\/doi.org\/10.1007\/s00417-013-2436-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,27]]}}}